These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The expression of prostate-specific membrane antigen in peripheral blood leukocytes. Lintula S; Stenman UH J Urol; 1997 May; 157(5):1969-72. PubMed ID: 9112573 [TBL] [Abstract][Full Text] [Related]
23. Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement. Murphy GP; Holmes EH; Boynton AL; Kenny GM; Ostenson RC; Erickson SJ; Barren RJ Prostate; 1995 Mar; 26(3):164-8. PubMed ID: 7534919 [TBL] [Abstract][Full Text] [Related]
24. Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigen. Murphy GP; Barren RJ; Erickson SJ; Bowes VA; Wolfert RL; Bartsch G; Klocker H; Pointner J; Reissigl A; McLeod DG; Douglas T; Morgan T; Kenny GM; Ragde H; Boynton AL; Holmes EH Cancer; 1996 Aug; 78(4):809-18. PubMed ID: 8756376 [TBL] [Abstract][Full Text] [Related]
25. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707 [TBL] [Abstract][Full Text] [Related]
26. Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction. Gao CL; Dean RC; Pinto A; Mooneyhan R; Connelly RR; McLeod DG; Srivastava S; Moul JW J Urol; 1999 Apr; 161(4):1070-6. PubMed ID: 10081840 [TBL] [Abstract][Full Text] [Related]
28. Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. Su SL; Huang IP; Fair WR; Powell CT; Heston WD Cancer Res; 1995 Apr; 55(7):1441-3. PubMed ID: 7882349 [TBL] [Abstract][Full Text] [Related]
29. The use of real-time quantitative PCR to detect circulating prostate-specific membrane antigen mRNA in patients with prostate carcinoma. Chu DC; Chuang CK; Liou YF; Tzou RD; Lee HC; Sun CF Ann N Y Acad Sci; 2004 Jun; 1022():157-62. PubMed ID: 15251956 [TBL] [Abstract][Full Text] [Related]
30. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer. Gomella LG; Raj GV; Moreno JG J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297 [TBL] [Abstract][Full Text] [Related]
31. Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patients. Rochon YP; Horoszewicz JS; Boynton AL; Holmes EH; Barren RJ; Erickson SJ; Kenny GM; Murphy GP Prostate; 1994 Oct; 25(4):219-23. PubMed ID: 8084837 [TBL] [Abstract][Full Text] [Related]
32. The application of the RT-PCR method for the staging of the prostate cancer progression. Zummerova A; Labas P; Bohmer D; Blasko M; Polak S; Danisovic L; Repiska V Gen Physiol Biophys; 2010 Dec; 29(4):362-72. PubMed ID: 21156999 [TBL] [Abstract][Full Text] [Related]
33. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients. Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910 [TBL] [Abstract][Full Text] [Related]
34. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients. Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815 [TBL] [Abstract][Full Text] [Related]
35. Quantitative detection of micrometastases in pelvic lymph nodes in patients with clinically localized prostate cancer by real-time reverse transcriptase-PCR. Miyake H; Hara I; Kurahashi T; Inoue TA; Eto H; Fujisawa M Clin Cancer Res; 2007 Feb; 13(4):1192-7. PubMed ID: 17317829 [TBL] [Abstract][Full Text] [Related]
36. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Katz AE; Olsson CA; Raffo AJ; Cama C; Perlman H; Seaman E; O'Toole KM; McMahon D; Benson MC; Buttyan R Urology; 1994 Jun; 43(6):765-75. PubMed ID: 7515202 [TBL] [Abstract][Full Text] [Related]
37. Assessment of optimal target genes for detecting micrometastases in pelvic lymph nodes in patients with prostate cancer undergoing radical prostatectomy by real-time reverse transcriptase-polymerase chain reaction. Kusuda Y; Miyake H; Kurahashi T; Fujisawa M Urol Oncol; 2013 Jul; 31(5):615-21. PubMed ID: 21600799 [TBL] [Abstract][Full Text] [Related]
38. Detection of circulating prostate tumor cells: alternative spliced variant of PSM induced false-positive result. Hisatomi H; Nagao K; Kawakita M; Matsuda T; Hirata H; Yamamoto S; Nakamoto T; Harasawa H; Kaneko N; Hikiji K; Tsukada Y Int J Mol Med; 2002 Nov; 10(5):619-22. PubMed ID: 12373303 [TBL] [Abstract][Full Text] [Related]
39. Real-time quantitative RT-PCR assay of prostate-specific antigen and prostate-specific membrane antigen in peripheral blood for detection of prostate cancer micrometastasis. Zhang L; Wang CY; Yang R; Shi J; Fu R; Chen L; Klocker H; Zhang J Urol Oncol; 2008; 26(6):634-40. PubMed ID: 18367130 [TBL] [Abstract][Full Text] [Related]